Skandinaviska Enskilda Banken (SEB)
TRML

Skandinaviska Enskilda Banken (SEB)’s Tourmaline Bio TRML Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,921
Closed -$475K – 824
2025
Q3 		$475K Buy
+9,921
New +$275K ﹤0.01% 666

Skandinaviska Enskilda Banken (SEB)'s TRML Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 9,921 shares — an estimated $475K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $475K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 9,921 Tourmaline Bio shares in Q4 2025, an estimated $475K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Tourmaline Bio position peaked at $475K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.